3171 results for «3265»
3171 results
How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
17 May 2022 – From EuroPCR 2022
Watching this EuroPCR 2022 session on lifetime management of patients with aortic stenosis will help you understand the importance of the heart team in patient specific treatment and how procedural refinement may optimise long-term outcomes.
Stent failure: how to treat, how to prevent
18 May 2022 – From EuroPCR 2022
With 2 expert interviews, a stent failure case example, and a recorded best practice case to prevent stent failure in this EuroPCR 2022 session, understand why unraveling the mechanism of stent failure is essential for optimal treatment, receive tips and tricks to effectively treat stent failure,...
Robotic-assisted intervention: latest clinical insights and applications for complex PCI
18 May 2022 – From EuroPCR 2022
How does robotic assistance work in practice in the cathlab? This is the main question this EuroPCR 2022 session aims to answer. Watch it if you wish to understand the functions and capabilities of the Corpath GRX system, learn from a recorded case about best procedural practices and workflow...
Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release
18 May 2022 – From EuroPCR 2022
Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.
The right valve choice for TAVI patient longevity and durability
18 May 2022 – From EuroPCR 2022
Watch this session to learn about the impact of age and life expectancy on decision-making for TAVI, to become aware of the durability data of the current TAVI platform, and to revise contemporary implantation techniques and procedural goals for future TAVI-in-TAVI.
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
Mitral replacement: expanding patient options, even mitral annular calcification!
18 May 2022 – From EUROPCR 2022
The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.
The current role of paclitaxel DCB in PCI
18 May 2022 – From EuroPCR 2022
Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...
Looking at the heart and the brain - What is the role of LAA closure?
18 May 2022 – From EuroPCR 2022
Based on a pre-registered case study of a 68-year-old male patient, DG, who presented with atrial fibrillation, intracranial bleeding on warfarin, and compartment syndrome secondary to bleeding from warfarin, this EuroPCR 2022 session will allow you to discuss the challenges of treating AF patients with previous intracranial...
Low contrast complex PCI in a severely calcified lesion: the right tools and techniques
18 May 2022 – From EUROPCR 2022
In this session, you will learn how to perform an IVUS-guided low contrast PCI in patients with chronic kidney disease. Discover how to safely and effectively overcome wiring challenges in calcified tortuous coronaries and learn about the proper atherectomy device selection in challenging anatomies.
Learnings from an optimised TAVI patient's journey
18 May 2022 – From EUROPCR 2022
What are the best practices related to referring and in-hospital patient pathways? How and which TAVI procedural aspects can be optimised for the greater good of the patient and the healthcare system?
Watch this EuroPCR 2022 session to discover how an optimised TAVI care pathway offers...
Left main bifurcations: latest clinical data applied to practical cases
18 May 2022 – From EUROPCR 2022
Why should the stenting strategy be adapted to side branch lesion length? How to use intracoronary imaging to improve outcomes? This session will address those questions and show you through a series of cases, examples of left main PCI from the European Bifurcation Club main trial...
TAVI for aortic regurgitation - Addressing an unmet need with the JenaValve Trilogy heart valve system
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the unmet need in treating AR, to discover the performance of the Trilogy System (a new TAVI device for the treatment of AR), as well as to explore the future of TAVI for AR.
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
Your most challenging TAVI cases - Achieving precision and control with Evolut platform
18 May 2022 – From EuroPCR 2022
How to deal with challenging anatomies? Find answers in this EuroPCR 2022 session with case studies to explore and learn how to achieve optimal patient outcomes with Evolut platform, uncover practical tips and techniques to achieve implant precision and control, and become familiar with technical considerations and procedural execution...
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Incorporating coronary orbital atherectomy to my practice
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to examine the improvement of technology in the treatment of highly calcified coronary lesions: get a practical perspective on how to integrate and perform orbital atherectomy in your clinical practice, become aware of its differential aspects compared to other plaque preparation...
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
